Lincoln Pharmaceuticals Share Price
Know More₹811.70-3.80 (-0.47%)
20-Dec-2024₹812.10-1.45 (-0.18%)
20-Dec-2024BSE : 531633
NSE : LINCOLN
Sector : Health care
ISIN Code : INE405C01035
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 20-Dec-2024
| Market Cap (₹ Cr) | 1,626 |
Traded Value (₹ Cr) | 1.24 |
Volume (Shares) | 15,232 |
Face Value (₹) | 10 |
52-Week High (₹) | 975.00 |
52-Week High Date | 09-Dec-2024 |
52-Week Low (₹) | 498.00 |
52-Week Low Date | 05-Jun-2024 |
All Time High (₹) | 975.00 |
All Time High Date | 09-Dec-2024 |
All Time Low (₹) | 8.05 |
All Time Low Date | 12-Jun-2002 |
Lincoln Pharmaceuticals Ltd
Lincoln Pharma. News
Lincoln Pharma. Announcement
Lincoln Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 1,627 |
| EPS - TTM (₹) [C] | 48.25 |
| P/E Ratio (X) [C] | 16.83 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 18.00 |
| Latest Dividend Date | 13-Sep-2024 |
| Dividend Yield (%) | 0.22 |
| Book Value Share (₹) [C] | 319.16 |
| P/B Ratio (₹) [C] | 2.54 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.01 | 232 | 0.05 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 127 | 0.05 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 127 | 0.05 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 791.00 839.25 |
| Week Low/High (₹) | 791.00 942.00 |
| Month Low/High (₹) | 610.65 980.00 |
| Year Low/High (₹) | 534.80 980.00 |
| All time Low/High (₹) | 8.05 980.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -12.48% | -12.66% | -4.98 | -4.77% |
| 1 Month | 30.42% | 30.26% | 0.60 | 0.29% |
| 3 Month | 11.37% | 11.41% | -7.69 | -8.54% |
| 6 Month | 34.50% | 34.57% | 0.73 | 0.09% |
| 1 Year | 31.55% | 31.72% | 10.69 | 11.52% |
| 3 Year | 143.58% | 144.98% | 39.80 | 41.97% |
Company Info
Company Information
Chairman (Non-Executive) : Kishorbhai M Shah
Managing Director : Mahendra G Patel
Whole-time Director : Hasmukhbhai I Patel
Independent Director : Pirabhai R Suthar
Whole-time Director : Munjal Mahendrabhai Patel
Whole-time Director : Aashish R Patel
Independent Director : Meha Patel
Independent Director : Saurin J Parikh
Director : Rajnikant G Patel
Whole-time Director : Anand Arvindbhai Patel
Company Sec. & Compli. Officer : Trusha Shah
Registered Office: Lincoln House B/H Satyam Compe, Science City Road Sola,Ahmedabad,Gujarat-380060 Ph: 91-079-67778000
FAQs about Lincoln Pharmaceuticals Ltd
1. What's the Lincoln Pharmaceuticals Ltd share price today?
Lincoln Pharmaceuticals Ltd share price was Rs 811.70 at close on 20th Dec 2024. Lincoln Pharmaceuticals Ltd share price was down by 0.47% from the previous closing price of Rs 815.50. Lincoln Pharmaceuticals Ltd share price trend:
- Last 1 Month: Lincoln Pharmaceuticals Ltd share price moved up by 30.42% on BSE
- Last 3 Months: Lincoln Pharmaceuticals Ltd share price moved up by 11.37% on BSE
- Last 12 Months: Lincoln Pharmaceuticals Ltd share price moved up by 31.55% on BSE
- Last 3 Years: Lincoln Pharmaceuticals Ltd price moved up by 143.58% on BSE
2. How can I quickly analyse the performance of the Lincoln Pharmaceuticals Ltd stock?
The performance of the Lincoln Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 16.83
- Price to book value ratio is 2.54
- Dividend yield of 0.22
- The EPS (trailing 12 months) of the Lincoln Pharmaceuticals Ltd stock is Rs 48.25
3. What is the market cap of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd has a market capitalisation of Rs 1,626 crore.
4. What is Lincoln Pharmaceuticals Ltd's 52-week high/low share price?
The Lincoln Pharmaceuticals Ltd’s 52-week high share price is Rs 975.00 and 52-week low share price is Rs 498.00.
5. Is the Lincoln Pharmaceuticals Ltd profitable?
On a consolidated basis, Lincoln Pharmaceuticals Ltd reported a profit of Rs 26.33 crore on a total income of Rs 171.19 crore for the quarter ended 2024. For the year ended Sep 2024, Lincoln Pharmaceuticals Ltd had posted a profit of Rs 26.33 crore on a total income of Rs 171.19 crore.
6. Which are Lincoln Pharmaceuticals Ltd’s peers in the Health care sector?
Lincoln Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Sigachi Indust., Bliss GVS Pharma, Bajaj Healthcare, Lincoln Pharma., NGL Fine Chem, Fermenta Biotec., Anuh Pharma.
7. Who owns how much in Lincoln Pharmaceuticals Ltd?
Key changes to the Lincoln Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Lincoln Pharmaceuticals Ltd has gone down to 49.78 per cent as of Sep 2024 from 49.80 per cent as of Dec 2023.
